Harborside

Terranueva Corporation

Terranueva Corporation

Terranueva: Results of the Shareholders Meeting

Terranueva: Results of the Shareholders Meeting

L’ASSOMPTION, Quebec, April 14, 2022 -- Terranueva Corporation (CSE: TEQ) ("Terranueva") is pleased to announce the results of its annual and special meeting of shareholders held on April 14, 2022. The shareholders approved, by a majority of votes, a resolution to elect the following directors: Sylvain Aird, Marc-AndrĂ© AubĂ©, Marianne Fort... Read More...
Terranueva Obtains a Refinancing

Terranueva Obtains a Refinancing

L’ASSOMPTION, Quebec, Dec. 24, 2021 -- Terranueva Corporation (CSE: TEQ) ("Terranueva") is pleased to announce it has agreed to $133,333 in principal amount of convertible debenture (the “Debentures”) maturing on March 31, 2023, convertible into common shares of the capital stock of Terranueva at a conversion price of $0.15 per share subj... Read More...
Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development

Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development

L’ASSOMPTION, Quebec, April 07, 2021 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”), one of the 6 companies in QuĂ©bec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Canada Economic Development (“CED”) has granted the Corporatio... Read More...
Terranueva Announces Changes to Its Management Team

Terranueva Announces Changes to Its Management Team

MONTREAL, Nov. 02, 2020 -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”). The Board of Directors of Terranueva announced today a new organizational structure. Mr. Peter Polatos is appointed as interim President and Chief Executive Officer for the entire organization and also becomes a director of the Company."I am deli... Read More...
Terranueva receives $500,000 in assistance from the Canada Economic Development Agency for the regions of Quebec (CED)

Terranueva receives $500,000 in assistance from the Canada Economic Development Agency for the regions of Quebec (CED)

STOCK MARKET SYMBOL: TEQ L'ASSOMPTION, QC, Oct. 5, 2020 /CNW Telbec/ - Terranueva Corporation (CSE: TEQ) ("Terranueva"), one of six Quebec companies holding a license from Health Canada to develop cannabis-based medicinal products, is pleased to announce that the CED has granted a $500,000 repayable contribution to the Company in support ... Read More...
Terranueva Obtains $500,000 in Financial Support From Economic Development Canada

Terranueva Obtains $500,000 in Financial Support From Economic Development Canada

L’ASSOMPTION, Quebec, Sept. 24, 2020 -- Corporation Terranueva (CSE : TEQ) ) (the “Corporation” or “Terranueva”), one of the 6 companies in QuĂ©bec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Economic Development Canada (“EDC”) has granted a loan of $5... Read More...
Terranueva Corporation - Licence Amendment

Terranueva Corporation – Licence Amendment

L’ASSOMPTION, QuĂ©bec, Sept. 04, 2020 -- Corporation Terranueva (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has filed a licence amendment request with Health Canada to obtain the authorization to sell finished products in the retail cannabis market. Terranueva is now awaiting comments from Health Canada.Terranueva has... Read More...
Renunciation by LSL Laboratory to the Proposed Transaction with Terranueva

Renunciation by LSL Laboratory to the Proposed Transaction with Terranueva

L’ASSOMPTION, Quebec, July 15, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. ("Laboratoire LSL") announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.The Corpor... Read More...
Amendment of Warrants

Amendment of Warrants

L’ASSOMPTION, QuĂ©bec, May 29, 2020 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”) announces its intention to amend the term and exercise price of the 2,310,000 Series A warrants issued as part of a private placement which closed on December 14, 2018 (the “Warrants”). Under the current terms, each Warrant can be ... Read More...
Major Transaction With the Pharmaceutical LSL Laboratory Inc. for 23.7 Million Dollars

Major Transaction With the Pharmaceutical LSL Laboratory Inc. for 23.7 Million Dollars

L’ASSOMPTION, Quebec, March 27, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has reached a preliminary agreement, which became effective on March 26, 2020 following the consent of the two main creditors of Terranueva, with the owners of the pharmaceutical company LSL Laboratory Inc. (“LS... Read More...
Terranueva completes first harvest

Terranueva completes first harvest

L’ASSOMPTION, Quebec, July 17, 2019 -- Corporation Terranueva (CSE:TEQ) ("Terranueva") is pleased to announce the completion of its first harvest in its certification, research and development unit ("CRDU")."We are very pleased with the first results, the yield is higher than we expected, which allows us to confirm that our growing method... Read More...
Terranueva secures option for 280,000 sq. ft. to continue expansion plans at L'Assomption

Terranueva secures option for 280,000 sq. ft. to continue expansion plans at L’Assomption

MONTRÉAL, April 15, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that, following the issuance of culture, transformation and sale (medical) licenses issued by Health Canada on February 22, the Company pursued its development plan by securing contingent options to purchase over 280,000... Read More...
Private Placement of $366,666

Private Placement of $366,666

MONTRÉAL, Feb. 19, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) is pleased to announce that it has completed a private placement for an aggregate amount of $366,666 in common shares at a price of $0.50 per share, representing an aggregate of 733 332 shares of the capital stock of Terranueva. This private placement comes ... Read More...
Terranueva Grants Options

Terranueva Grants Options

MONTRÉAL, Feb. 05, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announces the grant to its directors, officers, employees and consultants of an aggregate of 2,225,000 stock options to acquire the same number of common shares of the capital stock of the Corporation at an exercise price $0.50 per share for a period between... Read More...
Terranueva Corporation to Begin Trading on the Canadian Securities Exchange

Terranueva Corporation to Begin Trading on the Canadian Securities Exchange

MONTREAL, Dec. 17, 2018 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announced that its common shares (“Common Shares”) will be listed and begin trading today on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “TEQ”. Terranueva Pharma is a private QuĂ©bec-based Company operating in L’Assomption (QuĂ©bec) th... Read More...
Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000

Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000

MONTREAL, Dec. 17, 2018 -- Terranueva Corporation (the “Corporation” or “Terranueva”) (TEQ.CN) is pleased to announce the closing of a private placement and of the transaction of $10 930 000 with Terranueva Pharma Corporation (“Terranueva Pharma”) consisting of a reverse takeover between the shareholders of Terranueva Pharma and Axe Explo... Read More...